Literature DB >> 19064578

No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk.

Victoria L Stevens1, Carmen Rodriguez, Juzhong Sun, Jeffrey T Talbot, Michael J Thun, Eugenia E Calle.   

Abstract

One-carbon metabolism mediates the interconversion of folates for the synthesis of precursors used in DNA synthesis, repair, and methylation. Inadequate folate nutrition or compromised metabolism can disrupt these processes and facilitate carcinogenesis. In this study, we investigated associations of 39 candidate single nucleotide polymorphisms (SNP) in 9 one-carbon metabolism genes with risk of prostate cancer using 1,144 cases and 1,144 controls from the Cancer Prevention Study-II Nutrition Cohort. None of these SNPs were significantly associated with prostate cancer risk, either overall or in cases with advanced prostate cancer. Thus, our findings do not support the hypothesis that common genetic variation in one-carbon metabolism genes influences prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064578      PMCID: PMC2645230          DOI: 10.1158/1055-9965.EPI-08-0789

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.

Authors:  Enrico Rossi; Joseph Hung; John P Beilby; Matthew W Knuiman; Mark L Divitini; Helen Bartholomew
Journal:  Ann Epidemiol       Date:  2005-12-15       Impact factor: 3.797

3.  Dietary factors of one-carbon metabolism and prostate cancer risk.

Authors:  Stephanie J Weinstein; Rachael Stolzenberg-Solomon; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Clin Nutr       Date:  2006-10       Impact factor: 7.045

4.  Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.

Authors:  Richard A Hubner; Kenneth R Muir; Jo-Fen Liu; Gabrielle S Sellick; Richard F A Logan; Matthew Grainge; Nicholas Armitage; Ian Chau; Richard S Houlston
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-09       Impact factor: 4.254

5.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

6.  Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma.

Authors:  F Kimura; K H Franke; C Steinhoff; K Golka; H C Roemer; A G Anastasiadis; W A Schulz
Journal:  Prostate       Date:  2000-11-01       Impact factor: 4.104

7.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

8.  A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer.

Authors:  Bastiaan T Heijmans; Jolanda M A Boer; H Eka D Suchiman; Cees J Cornelisse; Rudi G J Westendorp; Daan Kromhout; Edith J M Feskens; P Eline Slagboom
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

9.  Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals.

Authors:  Daniel O Stram; Celeste Leigh Pearce; Phillip Bretsky; Matthew Freedman; Joel N Hirschhorn; David Altshuler; Laurence N Kolonel; Brian E Henderson; Duncan C Thomas
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

10.  Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.

Authors:  C Marchal; M Redondo; A Reyes-Engel; E Perea-Milla; M J Gaitan; J Machuca; F Diaz; J Caballero; J Carnero
Journal:  Eur J Surg Oncol       Date:  2007-10-29       Impact factor: 4.424

View more
  14 in total

Review 1.  Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.

Authors:  Sergey A Krupenko; Natalia I Krupenko
Journal:  Chem Biol Interact       Date:  2019-02-20       Impact factor: 5.192

2.  Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms on homocysteine.

Authors:  Carlos J García-Minguillán; Joan D Fernandez-Ballart; Santiago Ceruelo; Lídia Ríos; Olalla Bueno; Maria Isabel Berrocal-Zaragoza; Anne M Molloy; Per M Ueland; Klaus Meyer; Michelle M Murphy
Journal:  Genes Nutr       Date:  2014-10-17       Impact factor: 5.523

3.  No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: A meta-analysis.

Authors:  Dawei Li; Tian Tian; Chunhui Guo; Juchao Ren; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Exp Ther Med       Date:  2012-01-04       Impact factor: 2.447

4.  Lack of association between methylenetetrahydrofolate dehydrogenase 1 G1958A polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Guizhong Liu; Can Qi; Qingzhu Xu; Baojun Wu; Yingjie Wang; Chunxiao Xue
Journal:  Tumour Biol       Date:  2013-10-03

Review 5.  MTHFR C677T gene polymorphism and head and neck cancer risk: a meta-analysis based on 23 publications.

Authors:  Yu-Ming Niu; Mo-Hong Deng; Wen Chen; Xian-Tao Zeng; Jie Luo
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

6.  Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.

Authors:  Hongtuan Zhang; Hui Ma; Liang Li; Zhihong Zhang; Yong Xu
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

7.  ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.

Authors:  Guangzhi Zhu; Xiwen Liao; Chuangye Han; Xiaoguang Liu; Long Yu; Wei Qin; Sicong Lu; Hao Su; Zhiwei Chen; Zhengtao Liu; Yu Liang; Jianlu Huang; Tingdong Yu; Chengkun Yang; Ketuan Huang; Liming Shang; Xinping Ye; Lequn Li; Xue Qin; Kaiyin Xiao; Minhao Peng; Tao Peng
Journal:  Oncol Rep       Date:  2017-07-14       Impact factor: 3.906

8.  Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies.

Authors:  Ping Wang; Sanqiang Li; Meilin Wang; Jing He; Shoumin Xi
Journal:  J Cancer       Date:  2017-01-15       Impact factor: 4.207

9.  Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans.

Authors:  Adriana C Vidal; Delores J Grant; Christina D Williams; Elizabeth Masko; Emma H Allott; Kathryn Shuler; Megan McPhail; Alexis Gaines; Elizabeth Calloway; Leah Gerber; Jen-Tsan Chi; Stephen J Freedland; Cathrine Hoyo
Journal:  J Cancer Epidemiol       Date:  2012-08-09

10.  Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism.

Authors:  Aristea Binia; Alejandra V Contreras; Samuel Canizales-Quinteros; Victor Acuña Alonzo; M Elizabeth Tejero; Irma Silva-Zolezzi
Journal:  Genes Nutr       Date:  2014-08-09       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.